Drug | The Diabetes Zone

Kidney drug fails to work in international trial

Kidney drug fails to work in international trial
WASHINGTON — A drug known as sulodexide has failed to show any benefit toward halting kidney failure in people with diabetes and an international trial has been stopped early, a US medical journal said Thursday. The drug, once seen as a potentially …
Read more on AFP

Positive Data on Vivus' ED Drug

Positive Data on Vivus' ED Drug
Vivus Inc. (VVUS – Snapshot Report) recently presented positive data from a late-stage trial on its erectile dysfunction (ED) candidate, avanafil, at the 47th European Association for the Study of Diabetes Annual Meeting. The REVIEW-Diabetes study …
Read more on Zacks.com

Diabetes Drug Fights Breast Cancer

Diabetes Drug Fights Breast Cancer
By Linda Fugate PhD HERWriter August 22, 2011 – 5:46am A common drug used to treat type 2 diabetes may soon join the arsenal of treatments for breast cancer. Metformin (brand names Glucophage, Glumetza, Fortamet, and Riomet) has several biochemical …
Read more on EmpowHer

Diabetes drug Actos reduces risk of developing the disease

Diabetes drug Actos reduces risk of developing the disease
The diabetes drug Actos reduces the possibility of developing Type 2 diabetes for high-risk patients, study finds. Taking the diabetes drug Actos every day reduced the chance of developing Type 2 diabetes by two-thirds in people whose obesity, ethnicity, family history and other factors put them at

Failure of diabetes drug is a setback for Tolerx

Failure of diabetes drug is a setback for Tolerx
Some bad news from Cambridge-based Tolerx Inc. : The biotechnology company and a partner, GlaxoSmithKline PLC , report their experimental drug for Type 1 diabetes failed to meet the main clinical goal of a late-stage study.
Read more on Boston Globe

New study adds weight to diabetes drug link to heart problems

New study adds weight to diabetes drug link to heart problems
A new study published on bmj.com today adds to mounting evidence that rosiglitazone — a drug used to treat Type 2 diabetes — is associated with an increased risk of major heart problems.
Read more on EurekAlert!

Drug used to treat type 2 diabetes linked to heart problems

Drug used to treat type 2 diabetes linked to heart problems
London, March 18 (ANI): A new study has added to mounting evidence that rosiglitazone – a drug used to treat type 2 diabetes – is associated with an increased risk of major heart problems.
Read more on ANI via Yahoo! India News

Experimental Diabetes Drug Taspoglutide Late-Stage Trials Suspended

Experimental Diabetes Drug Taspoglutide Late-Stage Trials Suspended
Experimental diabetes drug, taspoglutide, a joint development between Roche (Switzerland) and Ipsen (France), had its late-stage trials suspended because of side effects. Roche announced that it had stopped giving patients taspoglutide because of adverse gastrointestinal reactions. The drug already has some “hypersensitivity problems”. The Swiss pharmaceutical company says it

Controversial Diabetes Drug Harms Heart, U.S. Concludes

Waging the battle against diabetes
VIRGINIA — The nationwide diabetes epidemic could virtually be eliminated with lifestyle changes, Dr. Robert Sjoberg told a packed auditorium at the Virginia Regional Medical Center Tuesday afternoon.

The Diabetes Zone

Pages

Categories

Archives

Kidney drug fails to work in international trial

Positive Data on Vivus' ED Drug

Diabetes Drug Fights Breast Cancer

Diabetes drug Actos reduces risk of developing the disease

Failure of diabetes drug is a setback for Tolerx

New study adds weight to diabetes drug link to heart problems

Drug used to treat type 2 diabetes linked to heart problems

Experimental Diabetes Drug Taspoglutide Late-Stage Trials Suspended

Controversial Diabetes Drug Harms Heart, U.S. Concludes

“Must Read” Posts for New Diabetics

How to Control Type 2 Diabetes with Your Diet

Diet Plan for Diabetics

Bestselling Diabetic Supplies & Books on Amazon

Bestselling Books

Recent Posts

Recent Comments

Meta